{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:20:07Z","timestamp":1786994407833,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.msard.2019.07.002","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T19:37:14Z","timestamp":1562096234000},"page":"42-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Higher health care use before a clinically isolated syndrome with or without subsequent MS"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1855-5595","authenticated-orcid":false,"given":"Ruth Ann","family":"Marrie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.A.","family":"Wijnands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Kingwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinshan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okechukwu","family":"Ekuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinya","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1409-0214","authenticated-orcid":false,"given":"Charity","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Fisk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5804-2535","authenticated-orcid":false,"given":"Helen","family":"Tremlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.msard.2019.07.002_bib0001","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1017\/cjn.2017.301","article-title":"Establishing the incidence and prevalence of multiple sclerosis in Saskatchewan.","volume":"45","author":"Al-Sakran","year":"2018","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.msard.2019.07.002_bib0002","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/archopht.121.7.944","article-title":"High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial","volume":"121","author":"Beck","year":"2003","journal-title":"Arch. Ophthalmol."},{"issue":"11","key":"10.1016\/j.msard.2019.07.002_bib0003","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1177\/1352458513477924","article-title":"Fatigue heralding multiple sclerosis","volume":"19","author":"Berger","year":"2013","journal-title":"Multiple Sclerosis J."},{"issue":"10","key":"10.1016\/j.msard.2019.07.002_bib0004","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/oxfordjournals.aje.a009735","article-title":"Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian Province: a population-based study","volume":"149","author":"Bernstein","year":"1999","journal-title":"Am. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.msard.2019.07.002_bib0005","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/ana.24769","article-title":"Pre-clinical disease activity in multiple sclerosis: a prospective study on cognitive performance prior to first symptom","volume":"80","author":"Cortese","year":"2016","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2019.07.002_bib0006","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/ana.25247","article-title":"Prodromal symptoms of multiple sclerosis in primary care","volume":"83","author":"Disanto","year":"2018","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2019.07.002_bib0007","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/neur.1995.0011","article-title":"\"Olfactory testing as an aid in the diagnosis of parkinson's Disease: development of optimal discrimination criteria","volume":"4","author":"Doty","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.msard.2019.07.002_bib0008","unstructured":"Hertzmark E. and Spiegelman D. (2012). The SAS METAANAL macro."},{"issue":"11","key":"10.1016\/j.msard.2019.07.002_bib0009","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/j.msard.2019.07.002_bib0010","article-title":"Prevalence and incidence of rheumatoid arthritis in canadian first nations and non-first nations People: a population-based study","author":"Hitchon","year":"2019","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.msard.2019.07.002_bib0011","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1874364101206010065","article-title":"Optic neuritis, its differential diagnosis and management","volume":"6","author":"Hoorbakht","year":"2012","journal-title":"Open Ophthalmol. J."},{"issue":"4","key":"10.1016\/j.msard.2019.07.002_bib0012","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1600-0404.2012.01703.x","article-title":"\"The socioeconomic consequences of optic neuritis with and without multiple sclerosis: a controlled national study","volume":"127","author":"Jennum","year":"2013","journal-title":"Acta Neurol. Scand."},{"issue":"4","key":"10.1016\/j.msard.2019.07.002_bib0013","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/art.39603","article-title":"Review: preclinical rheumatoid Arthritis: progress toward prevention","volume":"68","author":"Mankia","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.msard.2019.07.002_bib0014","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.msard.2018.08.013","article-title":"Identifying optic neuritis and transverse myelitis using administrative data","volume":"25","author":"Marrie","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2019.07.002_bib0015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(11)70274-5","article-title":"\"Clinically isolated syndromes","volume":"11","author":"Miller","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2019.07.002_bib0016","unstructured":"National Institute of Allergy and Infectious Diseases (NIAID). (2015). \"Strategy to prevent the onset of clinically-apparent rheumatoid arthritis (StopRA) NCT02603146.\" Retrieved December 19, 2018, fromhttps:\/\/clinicaltrials.gov\/ct2\/show\/NCT02603146."},{"key":"10.1016\/j.msard.2019.07.002_bib0017","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1111\/j.1572-0241.2000.03361.x","article-title":"Identification of a prodromal period in crohn's disease but not ulcerative colitis","volume":"95","author":"Pimentel","year":"2000","journal-title":"Am. J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.msard.2019.07.002_bib0018","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1007\/s00296-011-2053-1","article-title":"\"Initial presentation of acute transverse myelitis in systemic lupus erythematosus: demographics, diagnosis, management and comparison to idiopathic cases","volume":"32","author":"Schulz","year":"2012","journal-title":"Rheumatol. Int."},{"issue":"7","key":"10.1016\/j.msard.2019.07.002_bib0019","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1177\/1352458514554054","article-title":"\"School performance as a marker of cognitive decline prior to diagnosis of multiple sclerosis","volume":"21","author":"Sinay","year":"2015","journal-title":"Multiple Sclerosis J."},{"issue":"23","key":"10.1016\/j.msard.2019.07.002_bib0020","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1212\/01.wnl.0000436934.40034eb","article-title":"Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination","volume":"81","author":"van Pelt","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2019.07.002_bib0021","first-page":"398","article-title":"\"Population-based use of mental health services and patterns of delivery among family physicians, 1992 to 2001","volume":"50","author":"Watson","year":"2005","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.msard.2019.07.002_bib0022","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. (2011). \"Anatomic therapeutic chemical classification system.\" Retrieved August 9, 2012, fromhttp:\/\/www.whocc.no\/atc\/structure_and_principles\/."},{"issue":"6","key":"10.1016\/j.msard.2019.07.002_bib0023","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1474-4422(17)30076-5","article-title":"Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study","volume":"16","author":"Wijnands","year":"2017","journal-title":"Lancet Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103481930286X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103481930286X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:47:30Z","timestamp":1761900450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103481930286X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":23,"alternative-id":["S221103481930286X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2019.07.002","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher health care use before a clinically isolated syndrome with or without subsequent MS","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2019.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}